Marendis
Marendis Therapeutics develops novel small molecule therapeutics targeting inflammatory pathways implicated in autoimmune diseases. The company focuses on creating orally bioavailable compounds with improved selectivity and reduced off-target effects compared to existing treatments. Their pipeline aims to address significant unmet medical needs in chronic inflammatory conditions through targeted pharmacological intervention.
Traction –/10
HQ unknown
Updated 5 months ago
Funding
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- Marendis Therapeutics develops novel small molecule therapeutics targeting inflammatory pathways implicated in autoimmune diseases. The company focuses on creating orally bioavailable compounds with improved selectivity and reduced off-target effects compared to existing treatments. Their pipeline aims to address significant unmet medical needs in chronic inflammatory conditions through targeted pharmacological intervention.